A closer look at LOC105374036: A Potential Drug Target and Biomarker
A closer look at LOC105374036: A Potential Drug Target and Biomarker
Introduction
LOC105374036 is a gene that has garnered significant attention in the scientific community due to its unique characteristics. It has been identified as a potential drug target and biomarker, making it an attractive subject for further investigation. In this article, we will provide a comprehensive overview of LOC105374036, including its structure, function, and potential as a drug target and biomarker.
Structure and Function
LOC105374036 is a gene located on chromosome 16, at position 736.2. It encodes a protein known as TSP3 (Tissue-Specific Plasma Protein 3), which is a protein that is expressed in various tissues and cells of the body. TSP3 is a member of the Integrin ?±6 (Ig) family, which is characterized by a conserved N-terminus, a transmembrane segment, and a C-terminus that contains a unique farnesylated cysteine ??????residue.
Ig?±6 is a type of transmembrane protein that plays a central role in various physiological processes, including cell adhesion, migration, and signaling. TSP3 has been shown to participate in several physiological processes, including cell-cell adhesion, migration, and the regulation of cell proliferation.
LOC105374036 has been identified as a potential drug target due to its unique structure and function. The conserved N-terminus and transmembrane segment of TSP3 make it a promising candidate for drug development. Additionally, the farnesylated cysteine ??????residue at the C-terminus of TSP3 could be a potential target for small molecules that can modulate its function and activity.
Potential as a Biomarker
LOC105374036 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The unique structure and function of TSP3 make it an attractive candidate for diagnostic and therapeutic applications.
In cancer, TSP3 has been shown to be involved in various signaling pathways, including the NF-kappa pathway and the Wnt pathway. Its expression has also been associated with the development and progression of several types of cancer, including breast, ovarian, and prostate cancer. Therefore, TSP3 could be a valuable biomarker for cancer diagnosis and treatment.
In neurodegenerative diseases, TSP3 has been shown to play a role in the regulation of neuronal function and the maintenance of neuronal integrity. Its dysfunction has been associated with various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Therefore, TSP3 could be a valuable biomarker for neurodegenerative diseases and could potentially serve as a therapeutic target.
In autoimmune disorders, TSP3 has been shown to play a role in the regulation of immune cell function and the development of autoimmune diseases. Its dysfunction has been associated with various autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. Therefore, TSP3 could be a valuable biomarker for autoimmune disorders and could potentially serve as a therapeutic target.
Conclusion
LOC105374036 is a gene that has potential as a drug target and biomarker. Its unique structure and function, as well as its potential involvement in various physiological processes and its association with disease, make it an attractive subject for further investigation. Further studies are needed to determine the full potential of LOC105374036 as a drug target and biomarker.
Protein Name: Uncharacterized LOC105374036
The "LOC105374036 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374036 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584 | LOC105374591 | LOC105374595 | LOC105374608 | LOC105374610 | LOC105374613 | LOC105374645 | LOC105374660 | LOC105374683 | LOC105374701 | LOC105374713 | LOC105374724 | LOC105374726 | LOC105374736 | LOC105374737 | LOC105374754 | LOC105374756 | LOC105374778 | LOC105374786 | LOC105374793 | LOC105374795 | LOC105374809 | LOC105374811 | LOC105374820 | LOC105374848 | LOC105374860 | LOC105374875 | LOC105374879 | LOC105374882 | LOC105374890 | LOC105374898 | LOC105374903 | LOC105374906 | LOC105374910 | LOC105374915 | LOC105374925 | LOC105374928 | LOC105374935 | LOC105374939 | LOC105374942 | LOC105374945 | LOC105374968 | LOC105374971 | LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016
